Lawyers Demand ABC Cease Promotion of Controversial Drug Remdesivir on "Doctor Odyssey" Amid Health Risk Allegations

WASHINGTON, DC - A group of attorneys representing over 1,500 individuals has issued a cease-and-desist letter demanding that ABC, Inc., and its affiliates halt the promotion of the experimental drug Remdesivir (Veklury®) in the pilot episode of the television series Doctor Odyssey. The letter accuses the network of falsely advertising the drug as a “miracle cure” while ignoring evidence of its alleged dangers and ineffectiveness.

The attorneys argue that their clients were coerced into taking Remdesivir under Emergency Use Authorization (EUA) without proper informed consent, a violation of federal and ethical standards. They claim that misinformation and withheld risk factors about the drug led to serious health consequences, including kidney failure, liver damage, and organ failure. Citing studies, including one published in the New England Journal of Medicine, they note Remdesivir was previously removed from Ebola trials due to high mortality rates.

The letter outlines demands for ABC to:

The attorneys claim that Remdesivir has been linked to heart complications, organ damage, and other severe side effects. They accuse ABC of participating in a "deliberate attempt to defraud the public" and warn of potential legal action, including lawsuits for fraud, conspiracy, and human rights violations.

The letter also highlights concerns about conflicts of interest, noting that the NIH panel recommending Remdesivir's EUA included members with financial ties to its manufacturer, Gilead Sciences. The attorneys argue that promoting the drug constitutes human experimentation in violation of the Nuremberg Code.

The attorneys have given ABC until December 31, 2024, to comply with their demands, warning of immediate legal action if the issues are not addressed.